-
Oct 17, 2025GMP Compliance InspectionIn September, the coated aldehyde oxygen starch workshop of our company will undergo the GMP compliance inspection conducted by the National Medica...view more -
Oct 16, 2025Kyushu Pharmaceutical: Vilazodone Hydrobromide Receives Approval Notice For C...Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has received the Approval Notice for Chemical Active Pharmaceutical Ingredient (API) Marketing Applicatio...view more -
Oct 13, 2025Shijiazhuang Yiling Pharmaceutical: Marketing Application For Letrozole Chemi...Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") announces that Wanyang Hengshui Pharmaceutical Co., Ltd., i...view more -
Oct 10, 2025Top Scientists Worldwide Gather in Shanghai To Discuss New Breakthroughs in L...Hosted by TimePie, a vertical media outlet focused on longevity science, the "6th Aging Intervention Forum" was successfully held in Shanghai from ...view more -
Oct 09, 2025Xinhua Pharmaceutical: The Marketing Application For Ethyl Eicosapentaenoate ...Shandong Xinhua Pharmaceutical Co., Ltd. ("Xinhua Pharmaceutical" or "the Company") has received the Approval Notice for Marketing Application of C...view more -
Sep 30, 2025HOLIDAY NOTICE2025 National Day and Mid-Autumn Festival Holiday Arrangement of Our Companyview more -
Sep 28, 2025Announcement By CDE On Issuing The Requirements For Compiling Module 2 Pharma...On August 28, the Center for Drug Evaluation (CDE) issued the "Requirements for Compiling Module 2 Pharmaceutical Documentation in Marketing Author...view more -
Sep 26, 2025Interpretation Of The State Council Executive Meeting | Regulating The Applic...The Executive Meeting of the State Council held on September 12 deliberated and adopted the Draft Regulation on the Administration of Clinical Rese...view more -
Sep 25, 2025The 'Pharmaceutical Goddess' Reveals Her Hidden Heavyweight Stock HoldingsChina-Europe Healthcare Mixed Fund: Currently the Largest Healthcare-Themed Fund in the Marketview more -
Sep 24, 2025Global Pharmaceutical Regulatory Dynamics in The Second Half Of 2025: Breakth...In the second half of 2025, the global pharmaceutical regulatory sector witnessed numerous highlights: a number of drugs obtained new approvals or ...view more -
Sep 22, 2025The rally of China's innovative pharmaceuticals is only just beginning.Since the start of this year, the innovative pharmaceutical sector has seen a strong rebound, attracting market attention. However, recently, the m...view more -
Sep 23, 2025International super buyers are on a spree snapping up China's innovative drugs.After a 7-fold surge this year, Harbour BioMed, a Biotech company listed on the Hong Kong Stock Exchange's 18A board, has welcomed a heavyweight bu...view more












